Zoetis (ZTS) Gross Margin (2012 - 2026)
Zoetis' (ZTS) quarterly Gross Margin came in at 71.66% in Q1 2026, down 22.0% year-on-year from 91.87% in Q1 2025, and up 2.12% on a QoQ basis from 70.17% in Q4 2025.
Zoetis (ZTS) Gross Margin (2012 - 2026) Analysis & Trends
Zoetis (ZTS) has 15 years of Gross Margin data on file, last reported at 71.66% in Q1 2026.
- On a quarterly basis, Gross Margin fell 22.0% year-over-year to 71.66% in Q1 2026; TTM through Mar 2026 was 71.76%, a 84.0% increase from a year earlier, with the FY2025 full-year figure at 71.84%, up 121.0% from the prior year.
- Gross Margin for Q1 2026 stood at 71.66%, up from 70.17% in the prior quarter.
- Over the last five years, Gross Margin for ZTS reached as high as 73.62% in Q2 2025 and fell as low as 67.1% in Q4 2023.
- Historically, Gross Margin has averaged 70.6% across 5 years, with a median of 70.64% in 2024.
- On a YoY basis, Gross Margin climbed as much as 3714 bps in 2022 and fell as far as 151 bps in 2022.
- Year by year, Gross Margin stood at 67.99% in 2022, then slipped by 1 bps to 67.1% in 2023, then increased by 4 bps to 69.49% in 2024, then increased by 1 bps to 70.17% in 2025, then climbed by 2 bps to 71.66% in 2026.
- Per Business Quant data, the three most recent Gross Margin figures were 71.66% in Q1 2026, 70.17% in Q4 2025, and 71.54% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 49.52% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 71.66% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 62.93% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 82.93% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 32.97% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 98.31% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.26% |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | 55.84% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 71.66% |
| Dec 31, 2025 | 70.17% |
| Sep 30, 2025 | 71.54% |
| Jun 30, 2025 | 73.62% |
| Mar 31, 2025 | 71.88% |
| Dec 31, 2024 | 69.49% |
| Sep 30, 2024 | 70.64% |
| Jun 30, 2024 | 71.71% |
| Mar 31, 2024 | 70.64% |
| Dec 31, 2023 | 67.10% |
| Sep 30, 2023 | 70.34% |
| Jun 30, 2023 | 72.16% |
| Mar 31, 2023 | 70.60% |
| Dec 31, 2022 | 67.99% |
| Sep 30, 2022 | 69.68% |
| Jun 30, 2022 | 69.54% |
| Mar 31, 2022 | 71.35% |
| Dec 31, 2021 | 69.50% |
| Sep 30, 2021 | 70.55% |
| Jun 30, 2021 | 70.84% |